Paper3981007
Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay.
Friguet B and 3 others. J Immunol Methods, 1985. Cited by 1,136 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. Papers, record 3981007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3981007
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Affinity | Major topic |
| Antigen-Antibody Complex | Major topic |
| Antibodies, Monoclonal | |
| Enzyme-Linked Immunosorbent Assay | |
| Solutions | |
| Spectrometry, Fluorescence | |
| Tryptophan Synthase |
Source PubMed
Cited by282
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,136 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,591,215 | Beyond enzyme engineering: ordered enzyme immobilization drives enhanced productivity in vitro. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42591215 | PubMed |
| 42,514,893 | Anti-PEG Immunogenicity of mRNA-LNP Vaccines in Humans: Evidence for Population-Level Changes in the Anti-PEG Antibody Repertoire. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514893 | PubMed |
| 42,058,901 | Infectious bursal disease virus suppresses humoral immunity via blocking antibody affinity maturation in chickens. | iScience | 2026 | https://conductscience.org/library/papers/42058901 | PubMed |
| 41,852,580 | Comparative analysis of anti-MICA scFv affinities: Insights from three label-free biophysical methods and biological validation. | Biotechnol Rep (Amst) | 2026 | https://conductscience.org/library/papers/41852580 | PubMed |
| 41,661,650 | A MERTK-Targeting Antibody-Drug Conjugate Selectively Depletes M2 Tumor-Associated Macrophages and MERTK-Expressing Cancer Cells. | Cancer Res | 2026 | https://conductscience.org/library/papers/41661650 | PubMed |
| 40,402,465 | Evaluation of proinsulin(F25D) as a targeting ligand for insulin-binding B cells in autoimmune diabetes. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/40402465 | PubMed |
| 39,384,892 | Biochemical rationale for transfusion of high titre COVID-19 convalescent plasma. | Sci Rep | 2024 | https://conductscience.org/library/papers/39384892 | PubMed |
| 39,336,102 | A New Chimeric Antibody against the HIV-1 Fusion Inhibitory Peptide MT-C34 with a High Affinity and Fc-Mediated Cellular Cytotoxicity. | Biology (Basel) | 2024 | https://conductscience.org/library/papers/39336102 | PubMed |
| 39,039,412 | Use of Single-Domain Antibodies Against the NSm Protein for the Detection of Cells Infected by Rift Valley Fever Virus. | Methods Mol Biol | 2024 | https://conductscience.org/library/papers/39039412 | PubMed |
| 38,980,046 | Phage display-derived alpaca nanobodies as potential therapeutics for Naja atra snake envenomation. | Appl Environ Microbiol | 2024 | https://conductscience.org/library/papers/38980046 | PubMed |
| 38,921,828 | Simple Determination of Affinity Constants of Antibodies by Competitive Immunoassays. | Methods Protoc | 2024 | https://conductscience.org/library/papers/38921828 | PubMed |
| 38,250,068 | SON-1210 - a novel bifunctional IL-12 / IL-15 fusion protein that improves cytokine half-life, targets tumors, and enhances therapeutic efficacy. | Front Immunol | 2023 | https://conductscience.org/library/papers/38250068 | PubMed |
| 38,225,756 | Advanced Tuneable Micronanoplatforms for Sensitive and Selective Multiplexed Spectroscopic Sensing via Electro-Hydrodynamic Surface Molecular Lithography. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38225756 | PubMed |
| 37,835,736 | IgY Antibodies from Birds: A Review on Affinity and Avidity. | Animals (Basel) | 2023 | https://conductscience.org/library/papers/37835736 | PubMed |
| 37,679,631 | Antibody Affinity and Stability Maturation by Error-Prone PCR. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/37679631 | PubMed |
| 37,679,300 | Modulating the RAGE-Induced Inflammatory Response: Peptoids as RAGE Antagonists. | Chembiochem | 2023 | https://conductscience.org/library/papers/37679300 | PubMed |
| 37,521,637 | Determination of the Dissociation Constant for Polyvalent Receptors Using ELISA: A Case of M13 Phages Displaying Troponin T-Specific Peptides. | ACS Omega | 2023 | https://conductscience.org/library/papers/37521637 | PubMed |
| 37,323,622 | Advancement in COVID-19 detection using nanomaterial-based biosensors. | Exploration (Beijing) | 2023 | https://conductscience.org/library/papers/37323622 | PubMed |
| 36,578,089 | Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer's disease brain extracts. | Alzheimers Res Ther | 2022 | https://conductscience.org/library/papers/36578089 | PubMed |
| 36,548,748 | Design of a Diagnostic Immunoassay for Aflatoxin M1 Based on a Plant-Produced Antibody. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/36548748 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3981007
GET https://conductscience.org/api/papers/v1/3981007/cited_by?page=2